H.R. 10369, Pharmacy Benefit Manager Transparency and Cost Control. Quorum's AI analysis reads it as a net benefit — and names who gains.
H.R. 10369 · Net good
What it does
This bill requires Medicare Part D and Medicare Advantage plans to use a standardized, transparent bidding process when selecting pharmacy benefit managers (PBMs), and mandates that plans choose the lowest-cost bid unless they can justify selecting a higher-cost option to advance specific program goals. It also requires PBMs to guarantee their cost projections and imposes new auditing, monitoring, and public reporting requirements on plans to ensure actual drug costs match what was promised in bids. Similar transparency rules apply to commercial health plans under ERISA.
The analysis names Medicare beneficiaries (lower out-of-pocket costs via reduced hidden PBM markups) — and 2 more groups — among the beneficiaries.
The trade-off
PBMs may respond by consolidating with larger health plans or insurers to avoid competitive pressure, potentially reducing independent PBM options and increasing vertical integration in drug distribution.
Transparency scores 75%, with a medium warning level and no provisions unrelated to the bill's subject.
Who is behind it
Filed by Ryan Mackenzie. Cosponsored by Carol Miller, Jake Auchincloss, Lucy McBath and Rick Allen.
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.